1'758 companies found
Biogen Switzerland AG
Baar · Since 1996
The core activity of Biogen is the research, development and production of medicines, in particular large and small molecular therapeutics, as well as biosimilars, with a focus on the treatment of severe diseases such as neurology, neuropsychiatry, immunology and rare diseases.
Bioggio Pharma Manufacture SA
Bioggio · Since 1973
BioXpress Therapeutics SA
Monthey · Since 2008
The core activity of BioXpress Therapeutics SA is the development and manufacturing of biosimilars, in particular monoclonal antibodies (mAb), as well as other biological medicines, including gene therapy and cell therapy candidates. The company focuses on developing high-quality, sustainably manufactured biosimilars that aim to improve access to life-saving treatments and reduce healthcare costs.
Blueprint Medicines (Switzerland) GmbH
Zug · Since 2018
Blueprint Medicines is a pharmaceutical company specializing in the development and marketing of innovative medicines. The company's core activity is the research, development and marketing of precision medicines, particularly for the treatment of cancer and other serious diseases. The company focuses on developing medicines that target specific molecular mechanisms, enabling more effective and safer treatment of patients.
Boiron SA
Avry-Sur-Matran · Since 2022
Caland SA
Delémont · Since 2019
Candoro ethics AG
Rotkreuz · Since 2023
CanVirex AG
Basel · Since 2017
The core activity of CanVirex AG is the development and research in the field of immunooncology and vaccination, particularly in biotechnology and pharmaceuticals. The company focuses on the development of viral vectors and immunotherapeutics.
Cartilla Therapeutics AG
Basel · Since 2024
CeiROx Life Sciences SA
Crans-Montana · Since 2007
Cellena AG
Riazzino · Since 2005
Cellestia Biotech AG
Basel · Since 2015
The core activity of Cellestia Biotech AG is the research and development of innovative approaches in biotechnology, particularly in the field of cancer research and treatment. The company focuses on the development of new therapies and treatment methods for cancer patients and works closely with academic and clinical partners.
Cemio Switzerland AG
Zurich · Since 2007
Chiesi SA
Villars-Sur-Glâne · Since 2015
The core activity of OM Pharma Schweiz is the development, manufacture and marketing of pharmaceuticals, particularly for the treatment of urinary tract infections, respiratory diseases and central nervous system disorders. The company offers specific products such as Trimbow and Uro-Vaxom and primarily targets healthcare professionals in Switzerland.
Chord Therapeutics SA
Eysins · Since 2014
Leika Bio AG
Basel · Since 2023
CONSULENZA ENERGETICA MULTI DIMENSIONALE MANUELA ANTONELLI
Bodio Ti · Since 2020
The company "NUOVEVIEDELLENERGIA" offers services in the field of bioenergetics, multidimensional tools and quantum techniques, with the aim of improving the quality of life of its customers. It also provides courses, workshops and online academies to support people in improving their own energy and well-being. The core activity of the company lies in the application of spiritual and energetic techniques to promote health, well-being and personal growth.
Creso Pharma Switzerland GmbH
Fribourg · Since 2023
Crinetics Pharmaceuticals Europe GmbH
Zug · Since 2024
CureVac Swiss AG
Basel · Since 2021
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register